» Articles » PMID: 10797573

Vimentin Expression in Human Squamous Carcinoma Cells: Relationship with Phenotypic Changes and Cadherin-based Cell Adhesion

Overview
Journal J Cell Biochem
Date 2000 May 8
PMID 10797573
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Phenotypic changes resembling an epithelial-to-mesenchymal transition often occur as epithelial cells become tumorigenic. Two proteins that have been implicated in this process are vimentin and N-cadherin. In this study, we sought to establish a link between expression of vimentin and N-cadherin as oral squamous epithelial cells undergo a morphologic change resembling an epithelial-to-mesenchymal transition. We found that N-cadherin and vimentin did not influence the expression of one another.

Citing Articles

Vimentin as a potential target for diverse nervous system diseases.

Chen K, Liu S, Li Y, He T, Zhao J, Wang T Neural Regen Res. 2022; 18(5):969-975.

PMID: 36254976 PMC: 9827761. DOI: 10.4103/1673-5374.355744.


The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.

Chen C, Yang C, Lin Y, Hou Y, Cheng T, Chang S Int J Mol Sci. 2021; 22(7).

PMID: 33917452 PMC: 8038731. DOI: 10.3390/ijms22073782.


Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance.

Hu H, Xu W, Zhang W, Yan X, Li Y, Li B Signal Transduct Target Ther. 2020; 5(1):271.

PMID: 33243974 PMC: 7693265. DOI: 10.1038/s41392-020-00275-8.


Expression of E-cadherin, vimentin and β-catenin in ameloblastoma and association with clinicopathological characteristics of ameloblastoma.

Hao F, Liu J, Zhong M, Wang J, Liu J Int J Clin Exp Pathol. 2020; 11(1):199-207.

PMID: 31938101 PMC: 6957967.


Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.

Semelakova M, Grauzam S, Betadthunga P, Tiedeken J, Coaxum S, Neskey D Transl Oncol. 2018; 12(1):49-61.

PMID: 30267961 PMC: 6160858. DOI: 10.1016/j.tranon.2018.09.006.